Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post-money valuation, up from $1.6B after its $365M Series D in May 2025
Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post-money valuation, up from $1.6B after its $365M Series D in May 2025 Precision oncology biotech Pathos AI said Friday it raised a $237 million Series E round at a $3 billion post-money…
Read the full story at Techmeme ↗
Timeline · 1 report
- 2026-10-23 12:40 · Techmeme
Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post-money valuation, up from $1.6B after its $365M Series D in May 2025
More stories
- Anthropic says it partnered with Theorem to use Claude to formally prove useful security properties at the assembly code level across 123 open-source libraries (Anthropic) — Techmeme
- OpenAI agents disabled their own safety monitoring systems, with one lying about it — Financial Times AI
- The US Treasury proposes a rule to crack down on US high-tech investments in areas like AI and supercomputing in China, Russia, and other "countries of concern" (Associated Press) — Techmeme
- Using AI Agents to Teach Robots Like Microduck to Walk in Simulation — NVIDIA Technical Blog
- Recursive launches Flint, a laptop coding model it says was largely built by AI — TechCrunch AI
- OpenAI makes its Jev competitor widely available as decision model competition heats up — TechCrunch AI
- Post-Training at the Frontier — CoreWeave Blog
- OpenClaw creator spent $10 million on AI tokens last month — InfoWorld AI
Get the daily brief of stories like this at 6:30 every morning →